Atlas Trials

A Continuation Trial for Subjects With Lupus Who Completed Protocol HGS1006-C1056 in the United States

Clinical trial NCT00724867 · COMPLETED

Trial details

NCT number
NCT00724867
Sponsor
Human Genome Sciences Inc., a GSK Company
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Systemic Lupus Erythematosus
Start date
2008-08-01
Primary completion
2015-03-01
Enrollment
268

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.